08048035996
Repatha 140 mg Good Quality Injection to UK - Birmingham | Phoenix Exim | Trusted Exporter

1. General Information

Repatha 140 mg Injection contains evolocumab, a monoclonal antibody used to help lower low-density lipoprotein cholesterol (LDL-C), commonly known as “bad cholesterol.” It is generally used along with an appropriate diet and other cholesterol-lowering treatment when additional LDL-C reduction is needed.

Repatha is a prescription medicine and should be used under the supervision of a qualified healthcare professional.

2. Product Information

  • Brand: Repatha
  • Active ingredient: Evolocumab
  • Strength: 140 mg
  • Dosage form: Injection
  • Drug class: PCSK9 inhibitor
  • Route: Subcutaneous injection
  • Manufacturer: Amgen
  • Storage: Store refrigerated as directed on the product packaging. Do not freeze or shake the medicine.
  • Prescription status: Prescription medicine

3. Uses of Repatha 140 mg Injection

Repatha may be prescribed for:

  • High LDL cholesterol (hypercholesterolemia)
  • Certain patients with familial hypercholesterolemia
  • Patients with established cardiovascular disease who require additional LDL-C lowering
  • Reducing the risk of certain cardiovascular events in appropriate high-risk patients

The exact indication and treatment plan depend on the patient's medical history and local prescribing guidelines.

4. Benefits of Repatha 140 mg Injection

The major potential benefits include:

  • Significant LDL-C reduction: Evolocumab can substantially reduce LDL cholesterol.
  • Additional cholesterol control: It can be used alongside statins or other lipid-lowering medicines when additional reduction is required.
  • Cardiovascular risk reduction: In appropriate patients with established cardiovascular disease, treatment can reduce the risk of certain major cardiovascular events.
  • Convenient dosing: Depending on the prescribed regimen, Repatha may be administered every two weeks or at another approved dosing schedule.

5. Side Effects of Repatha 140 mg Injection

Like all medicines, Repatha can cause side effects, although not everyone experiences them.

Possible adverse effects include:

  • Injection-site reactions
  • Allergic or hypersensitivity reactions
  • Muscle-related symptoms
  • Flu-like symptoms
  • Upper respiratory tract symptoms

Seek urgent medical attention if symptoms of a serious allergic reaction occur, such as swelling of the face, lips, tongue or throat, difficulty breathing, or severe rash.

6. Common Side Effects

Some commonly reported effects may include:

  • Redness, pain, bruising or swelling at the injection site
  • Back pain
  • Muscle pain
  • Joint pain
  • Nasopharyngitis or cold-like symptoms
  • Upper respiratory tract infection
  • Flu-like symptoms

The actual frequency can vary between patients and clinical studies.

7. How to Use Repatha 140 mg Injection

Repatha is administered under the skin (subcutaneously).

General instructions:

  1. Use Repatha only according to the prescription provided by your doctor.
  2. Follow the instructions supplied with the pre-filled pen or syringe.
  3. Common injection sites include the abdomen, thigh or upper arm, depending on the device and instructions.
  4. Rotate injection sites rather than repeatedly injecting into exactly the same location.
  5. Do not inject into skin that is tender, bruised, red or hardened.
  6. Do not shake the medicine.
  7. Dispose of used injection devices safely according to local requirements.

The dose and frequency should be determined by the prescribing healthcare professional.

8. How Repatha Works

Repatha contains evolocumab, which is a PCSK9 inhibitor.

PCSK9 is a protein that contributes to the breakdown of LDL receptors on liver cells. These receptors help remove LDL cholesterol from the bloodstream.

Evolocumab binds to and inhibits PCSK9. This allows more LDL receptors to remain available on liver cells, increasing the removal of LDL cholesterol from the blood and consequently lowering LDL-C levels.

9. Safety Advice

  • Use Repatha only under medical supervision.
  • Tell your doctor about any allergies before treatment.
  • Inform your doctor about all medicines and supplements you are taking.
  • Follow the prescribed dosing schedule carefully.
  • Store the medicine according to the manufacturer's instructions.
  • Do not freeze or shake the injection.
  • Allow the medicine to reach the recommended temperature according to the product instructions before administration.
  • Do not use the injection if the solution appears abnormal or the packaging/device is damaged.
  • Seek immediate medical attention for symptoms of a severe allergic reaction.
  • Pregnant or breastfeeding patients should discuss Repatha treatment with their healthcare professional.
  • Continue prescribed diet, exercise and other cholesterol medicines unless your doctor advises otherwise.

10. Frequently Asked Questions (FAQs)

Q1. What is Repatha 140 mg Injection used for?
Repatha is used to lower LDL cholesterol in appropriate patients and, in certain patients with cardiovascular disease, to reduce the risk of specified cardiovascular events.

Q2. What is the active ingredient in Repatha?
The active ingredient is evolocumab.

Q3. How is Repatha administered?
It is administered as a subcutaneous injection, meaning it is injected under the skin.

Q4. Can Repatha be taken with statins?
Yes. Repatha may be prescribed together with statins or other lipid-lowering medicines when additional LDL-C reduction is required.

Q5. How should Repatha be stored?
It is generally stored refrigerated. Follow the storage instructions supplied with the specific product and packaging.

Q6. Can I stop Repatha on my own?
No. Speak with your doctor before stopping treatment.

Q7. What should I do if I miss a dose?
Follow the missed-dose instructions provided with your product and contact your healthcare professional if you are unsure when to administer the next dose.

Q8. Is Repatha available as a 140 mg injection?
Yes. Repatha is available in a 140 mg subcutaneous presentation, with the exact device and packaging depending on the market.

11. Substitute for Repatha 140 mg Injection

A substitute should not be selected solely on the basis of the strength. The appropriate alternative depends on the patient's diagnosis, LDL-C level, cardiovascular risk, previous treatment and physician's recommendation.

Possible therapeutic alternatives may include other PCSK9 inhibitors or lipid-lowering medicines, such as:

  • Alirocumab
  • Inclisiran
  • High-intensity statins
  • Ezetimibe

These medicines are not automatically interchangeable with Repatha. A healthcare professional should determine the appropriate alternative.

12. SEO Keywords

  • Repatha 140 mg Injection exporter from India
  • Repatha 140 mg Injection supplier India
  • Repatha 140 mg Injection pharmaceutical exporter
  • Repatha 140 mg Injection wholesale supplier
  • Repatha 140 mg Injection export from Nagpur
  • Repatha 140 mg Injection exporter Nagpur India
  • Evolocumab 140 mg Injection supplier India
  • Evolocumab 140 mg pharmaceutical exporter
  • Repatha 140 mg Injection B2B supplier
  • Repatha 140 mg Injection international supplier
  • Repatha 140 mg Injection supplier USA
  • Repatha 140 mg Injection supplier UK
  • Repatha 140 mg Injection supplier Australia
  • Repatha 140 mg Injection supplier Singapore
  • Repatha 140 mg Injection supplier Canada
  • Repatha 140 mg Injection supplier South Korea
  • Repatha 140 mg Injection supplier UAE
  • Evolocumab Injection exporter from India
  • PCSK9 inhibitor pharmaceutical supplier India
  • LDL cholesterol medicine exporter India
  • Cardiovascular medicine exporter from Nagpur
  • Prescription medicine exporter India
  • Pharmaceutical products exporter Nagpur
  • Trusted medicine exporter from India
  • Phoenix Exim pharmaceutical exporter
  • Phoenix Exim medicine exporter Nagpur
  • Phoenix Exim Repatha supplier
  • Repatha 140 mg international pharmaceutical supply
  • Evolocumab 140 mg B2B pharmaceutical supplier
  • Repatha 140 mg export supplier for international markets 

Aug 14th, 2026 3:42 PM

Keywords